PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Sep 15, 2026
4 Sep 15, 2026
8-K Sep 14, 2026 FORM 8-K
4 Aug 20, 2026
4 Aug 19, 2026
ARS Aug 14, 2026 ANNUAL REPORT
DEFA14A Aug 14, 2026 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
DEF 14A Aug 14, 2026 FORM DEF 14A
8-K Aug 6, 2026 FORM 8-K
10-Q Aug 6, 2026 FORM 10-Q
3 Jul 30, 2026
8-K Jul 21, 2026 FORM 8-K
4 Jun 29, 2026
10-Q May 7, 2026 FORM 10-Q
8-K May 7, 2026 FORM 8-K
8-K Apr 8, 2026 FORM 8-K
424B5 Apr 8, 2026 PROSPECTUS SUPPLEMENT
8-K Mar 30, 2026 FORM 8-K
10-K Mar 5, 2026 FORM 10-K
8-K Mar 5, 2026 FORM 8-K
8-K Feb 18, 2026 FORM 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
8-K Feb 10, 2026 FORM 8-K
4 Feb 6, 2026
← Newer Page 1 of 36 · 882 filings Older →